Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Bullboard (TSX:TRIL)

View:
Comment by crossfit11on Jan 10, 2020 10:16am

RE:Tread Lightly......

Volume lower?? Volume is greater than yesterday at this time especially on the Nasdaq
Post by 88guy88on Jan 10, 2020 10:02am

Tread Lightly......

look out for that whipsaw......volume lower today but the price is up.....last group of momentum buyers and then maybe a whipsaw...
Comment by harrison99on Jan 09, 2020 8:27pm

RE:14 mil traded on nasdaq today

There is a US subsidiary trading on  Nasdaq
Comment by harrison99on Jan 09, 2020 8:24pm

RE:RE:RE:Is it worth $24.00 USD?

Historically, sellers take profits on Friday, so I hope your spot on....so I can buy back in cheaper
Post by coolfooldumbguyon Jan 09, 2020 8:06pm

still holding this stock

it is really taking off,so glta shareholders.
Comment by harrison99on Jan 09, 2020 7:20pm

RE:RE:RE:watching this one for

I am crying and kicking myself and having my wife kick me too.  Had 10K shares at .35$.   Had in mind to buy 100000 shares for $35K because of money from house sale.  Couldn't ...more  
Comment by 88guy88on Jan 09, 2020 7:17pm

RE:RE:Is it worth $24.00 USD?

I think the surprise may be to the downside on Friday.....it ran way up today on good volume....but the first move up was on massive volume compared to today and the the price peeled off and today was ...more  
Post by 88guy88on Jan 09, 2020 2:23pm

Back to $2.07 CND

whipsaw stock for sure
Post by 88guy88on Jan 09, 2020 1:23pm

Is it worth $24.00 USD?

any analyst reports.....this is up big today and more investors will know the story tomorrow for another big run up
Comment by cpacon Jan 09, 2020 9:04am

RE:RE:TRIL at $1.30US, fair value estimate is $24.

Don't take my word for it; that comes from Bloom Burton... a broker that I have a ton of respect for... Think about it though... FTSV a company that's so 'all in' on the CD47 concept ...more  
Comment by birch1on Jan 08, 2020 6:36pm

RE:TRIL at $1.30US, fair value estimate is $24.

really?  $24?  doubt it, but like this for sure.
Post by cpacon Jan 08, 2020 10:33am

TRIL at $1.30US, fair value estimate is $24.

TRIL put out fantastic results yesterday.  Their CD-47 drugs have the potential to be best in class, providing another meaningful tool in the fight against cancer...  their closest ...more  
Post by DanielBlack23on Jan 08, 2020 12:12am

Something on Trillium

Check it out  https://cutt.ly/mriKMKE
Post by birch1on Jan 07, 2020 9:46am

news

I like how this is trading.
Comment by CleverInvestor2on Jan 02, 2020 11:02pm

RE:RE:watching this one for

I'm expecting a close tomorrow of $1.40-$1.60, it'll have another big jump towards $2 on Monday.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities